BHS-019

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBHS-019
Drug Alias Namebeta-hemolytic Streptococcus vaccine (Wyeth)BHS-019
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsBeta-hemolytic Streptococcus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Vaccines Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Vaccines Llc
Active IndicationsN/A
Inactive IndicationsBeta-hemolytic Streptococcus infection

Other Information

ATC CodeN/A
Related LinksN/A